b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="jbb" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1559924/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Targeted Delivery of siRNA</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559924/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Journal of Biomedicine and Biotechnology" /><meta name="citation_title" content="Targeted Delivery of siRNA" /><meta name="citation_authors" content="Sabrina Oliveira, Gert Storm, Raymond M. Schiffelers" /><meta name="citation_date" content="2006" /><meta name="citation_volume" content="2006" /><meta name="citation_doi" content="10.1155/JBB/2006/63675" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1559924/?report=abstract" /><meta name="citation_pmid" content="17057365" /><meta name="DC.Title" content="Targeted Delivery of siRNA" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Hindawi Limited" /><meta name="DC.Contributor" content="Sabrina Oliveira" /><meta name="DC.Contributor" content="Gert Storm" /><meta name="DC.Contributor" content="Raymond M. Schiffelers" /><meta name="DC.Date" content="2006" /><meta name="DC.Identifier" content="10.1155/JBB/2006/63675" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Targeted Delivery of siRNA" /><meta property="og:type" content="article" /><meta property="og:description" content="Therapeutic application of siRNA requires delivery to the correct&#10;intracellular location, to interact with the RNAi machinery within the&#10;target cell, within the target tissue responsible for the pathology. Each of&#10;these levels of targeting poses a significant ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559924/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-jbb.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1559924/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1559924/pdf/JBB2006-63675.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1AA2A3E99A02E10000000007120711.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/94/">J Biomed Biotechnol</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/131010/">v.2006; 2006</a></li><li class="accid">PMC1559924</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-jbb.gif" alt="Logo of jbb" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,500,57" alt="Journal\'s Home" title="Journal\'s Home" href="http://www.hindawi.com/journals/jbb/" ref="reftype=publisher&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="370,58,500,75" alt="Manuscript Submission" title="Manuscript Submission" href="http://mts.hindawi.com" ref="reftype=publisher&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="264,58,369,75" alt="Aims and Scope" title="Aims and Scope" href="http://www.hindawi.com/journals/jbb/aims.html" ref="reftype=publisher&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="148,58,263,75" alt="Author Guidelines" title="Author Guidelines" href="http://www.hindawi.com/journals/jbb/guidelines.html" ref="reftype=publisher&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="49,58,147,75" alt="Editorial Board" title="Editorial Board" href="http://www.hindawi.com/journals/jbb/editors.html" ref="reftype=publisher&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,58,48,75" alt="Home" title="Home" href="http://www.hindawi.com/journals/jbb/" ref="reftype=publisher&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">J Biomed Biotechnol</span>. 2006; 2006: 63675. </span></div><div><span class="fm-vol-iss-date">Published online 2006 Jun 25. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1155%2FJBB%2F2006%2F63675" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1155/JBB/2006/63675</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1559924</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/17057365">17057365</a></div></div></div></div><h1 class="content-title">Targeted Delivery of siRNA</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Oliveira%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17057365" class="affpopup" co-rid="_co_idm139967517194480" co-class="co-affbox">Sabrina Oliveira</a>,<sup></sup> <a href="/pubmed/?term=Storm%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17057365" class="affpopup" co-rid="_co_idm139967513145888" co-class="co-affbox">Gert Storm</a>,<sup></sup> and  <a href="/pubmed/?term=Schiffelers%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17057365" class="affpopup" co-rid="_co_idm139967517115824" co-class="co-affbox">Raymond M. Schiffelers</a><sup></sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139967517194480"><h3 class="no_margin">Sabrina Oliveira</h3><p>Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Room Z735A, PO Box 80082, 3508 Utrecht, The Netherlands</p><div>Find articles by <a href="/pubmed/?term=Oliveira%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17057365">Sabrina Oliveira</a></div></div><div id="_co_idm139967513145888"><h3 class="no_margin">Gert Storm</h3><p>Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Room Z735A, PO Box 80082, 3508 Utrecht, The Netherlands</p><div>Find articles by <a href="/pubmed/?term=Storm%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17057365">Gert Storm</a></div></div><div id="_co_idm139967517115824"><h3 class="no_margin">Raymond M. Schiffelers</h3><p>Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Room Z735A, PO Box 80082, 3508 Utrecht, The Netherlands</p><div>Find articles by <a href="/pubmed/?term=Schiffelers%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17057365">Raymond M. Schiffelers</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139967510059648_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139967510059648_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139967510059648_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139967510059648_ai" style="display:none"><div class="fm-affl" lang="en" id="a">Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Room Z735A, PO Box 80082, 3508 Utrecht, The Netherlands</div><div id="cor1">* Raymond M. Schiffelers: <a href="mailto:dev@null" data-email="ln.uu.mrahp@sreleffihcS.M.R" class="oemail">ln.uu.mrahp@sreleffihcS.M.R</a></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139967510059648_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2006 Feb 16; Revised 2006 May 2; Accepted 2006 May 2.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139967510059648_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2006 Sabrina Oliveira et al.</div><div class="license half_rhythm"><p id="__p1">This is an open access article distributed under the Creative Commons \n\t\t\t\tAttribution License, which permits unrestricted use, distribution, and reproduction \n\t\t\t\tin any medium, provided the original work is properly cited.</p></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1559924/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139967511450848" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139967511450848title">Abstract</h2><!--article-meta--><div><p id="__p2" class="p p-first-last">Therapeutic application of siRNA requires delivery to the correct\nintracellular location, to interact with the RNAi machinery within the\ntarget cell, within the target tissue responsible for the pathology. Each of\nthese levels of targeting poses a significant barrier. To overcome these\nbarriers several strategies have been developed, such as chemical\nmodifications of siRNA, viral nucleic acid delivery systems, and nonviral\nnucleic acid delivery systems. Here, we discuss progress that has been made\nto improve targeted delivery of siRNA in vivo for each of these strategies.</p></div></div><div id="__sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec1title">INTRODUCTION</h2><p id="__p3" class="p p-first">The functional mediators of RNA interference (RNAi) are small\ninterfering RNAs (siRNA) [<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072206">1</a>, \n<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072200">2</a>]. These double-stranded RNA\nmolecules are typically 19 to 23 nucleotides in length, and\nconsequently have a molecular weight of approximately 13 to\n15 kd and 38 to 46 negative charges. As a consequence, passive\ntransport over the lipophilic cell membrane is poor [<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072205">3</a>&#x02013;<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072234">5</a>].\nAt the same time, intracellular entry and translocation into the\ncytoplasm (and/or nucleus), where the RNAi machinery is located,\nis a prerequisite, for gene silencing activity [<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072223">6</a>&#x02013;<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_337483457">9</a>].\nMore importantly, for in vivo applications, intracellular entry\ninto the target cell within the diseased tissue is required and\nshould lead to appearance in the cytoplasm to silence the mRNA of\ninterest (<a href="/pmc/articles/PMC1559924/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). Ideally, siRNA should therefore\nbe targeted to three levels: to the target tissue, the target cell\ntype, and the subcellular compartment.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC1559924/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139967552402688" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1559924_JBB2006-63675.001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is JBB2006-63675.001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1559924/bin/JBB2006-63675.001.jpg" /></a></div><div id="largeobj_idm139967552402688" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1559924/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC1559924/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p39">Three levels of\ntargeting: preferably, siRNA should be targeted to the diseased\ntissue (I). Within this tissue it should be delivered to the\ncorrect cell type for silencing the mRNA of interest (II).\nFollowing entry of the target cell, siRNA should be delivered to\nthe cytoplasm (and/or nucleus) to interact with the components of\nthe RNAi machinery (III).</p></div></div></div><p id="__p4">Primary obstacles for achieving this in vivo include competitive uptake by\nnontarget cells, excretion in urine, degradation by nucleases, and endosomal\ntrapping.</p><p id="__p5">Some literature reports claim entry of siRNA in the target cells\nof the target tissue after intravenous injection [<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072245">10</a>]. The\nobservations have been attributed to translocation of siRNA over the cell membrane by a dsRNA-receptor, referred to in <em>Caenorhabditis elegans</em> as\nSID-1,which is responsible in this organism for systemic\nspreading of the silencing effects [<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072250">11</a>]. Indeed,\noverexpression of the mammalian homologue increases the\nintracellular uptake of siRNA [<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072203">12</a>]. In contrast, &#x0201c;naked&#x0201d;\nsiRNA is used by many researchers as a negative control which\nfails to produce silencing effects after injection in vivo and\neven after prolonged incubation of cells with high siRNA\nconcentrations in vitro. This lack of activity of &#x0201c;naked&#x0201d; siRNA\nindicates that not all cell types express (enough of) the SID-1\nhomologue, to observe silencing effects. In addition, the rapid\nremoval of &#x0201c;naked&#x0201d; siRNA after intravenous administration from\nthe circulation, with more than 99% of the injected dose\nrenally excreted and taken up by liver Kupffer cells within\nminutes, makes a very small percentage of the administered dose\navailable for the target tissue. This small percentage is\nadditionally subject to nuclease degradation. Therefore,\nintravenous injection of naked siRNA relying on passive targeting\nof the diseased tissue, and SID-1 homologue-mediated target cell\nuptake seem to be inefficient and as yet unpredictable.</p><p id="__p6">Local injection at the site of pathology avoids many of the\ndifficulties encountered after intravenous administration, most\nnotably the rapid elimination, and is therefore a popular approach\nto increase target tissue concentrations of siRNA. With this approach \nchances of obtaining sufficient intracellular levels of siRNA for therapeutic effects are \nincreased [<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072215">13</a>, \n<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072226">14</a>]. Furthermore, helper molecules \n(like cationic lipids or polymers) or physical methods (like electroporation,\nsonoporation, or hydrodynamic pressure) can be employed to\nfacilitate intracellular entrance of siRNA [<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072214">13</a>, <a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072212">15</a>&#x02013;<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072228">19</a>]. In addition, local production of siRNA by genes encoding for short hairpin RNA (shRNA) can ensure prolonged levels of the\ndsRNA intracellularly [<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072224">20</a>, <a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072220">21</a>]. The encoding genes can be\ndelivered by viral vectors or one of the aforementioned nonviral methods.</p><p id="__p7">Unfortunately, local administration is not always feasible because the\ntarget tissue cannot be reached, or covers an area that is too large to be\nfeasible for a local injection protocol. In addition, using local injection\n(possibly supplemented with helper molecules or physical stimuli)\nselectivity in delivery to nontarget and target cell types has usually not\nbeen taken into account. This is an important aspect when considering the\nnonspecific effects that can be induced by dsRNA. Over the past few years,\nit has become clear that cells can respond strongly to siRNA by different\nproinflammatory reactions depending on cell type, siRNA sequence, and\nintracellular location\n[<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_337483458">22</a>&#x02013;<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_337483461">24</a>]. These\neffects can be intensified by employing cationic helper molecules\n[<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072218">25</a>], an effect probably mediated by a change in the intracellular trafficking of the dsRNA [<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072233">23</a>]. As a consequence, nontarget cells may also take up siRNA and respond with induction of\nproinflammatory pathways in addition to the therapeutic RNAi effects within\nthe target cells at the diseased site.</p><p id="__p8" class="p p-last">In this review we will focus on strategies for targeted siRNA delivery that\nare designed to improve accumulation of siRNA at three in vivo levels of\ndelivery: at the target tissue, the target cell, and at the intracellular\ntarget site of action. We will concentrate on delivery approaches for\nsystemic administration as such systems have broadest applicability. Three\napproaches will be discussed:\n\n</p><ol class="enumerated" style="list-style-type:decimal"><!--\nlist-behavior=enumerated\nprefix-word=\nmark-type=decimal\nmax-label-size=0\n--><li><p id="__p9">chemical modifications of siRNA,</p></li><li><p id="__p10">viral nucleic acid delivery systems,</p></li><li><p id="__p11">nonviral nucleic acid delivery systems.</p></li></ol><p>\n\nMost attention will be given to in vivo delivery strategies, as in vitro\ntargeting studies often do not represent a fair evaluation of the many\nbarriers that exist in vivo, possibly impeding efficient and site-specific\ndelivery (eg, phagocyte uptake, uptake by competing cell types, excretion,\nintracellular processing, and siRNA (delivery system) stability).</p></div><div id="__sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec2title">CHEMICAL MODIFICATIONS</h2><p id="__p12" class="p p-first">The nuclease sensitivity and poor tissue distribution/membrane permeation\nqualities of siRNA provide a reason to investigate possible chemical\nmodifications that would improve these characteristics which would not\ninterfere with the silencing efficiency of the molecules. Several strategies\nhave been proposed to improve nuclease resistance and target cell uptake.</p><div id="__sec3" class="sec"><h3 id="__sec3title">Increasing nuclease resistance</h3><p id="__p13" class="p p-first">Chemical modifications in the nucleobases, sugars, and the phosphate ester\nbackbone of siRNA can reduce siRNA sensitivity to nucleases\n[<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072217">26</a>&#x02013;<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072222">28</a>]. Initial studies centered on\nthe tolerance of the RNAi system for modifications in the two RNA strands\n[<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072243">29</a>]. A number of chemical modifications have been proposed to increase nuclease resistance, like boranophosphates\n[<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072242">30</a>], 4&#x02032;-thioribonucleosides, phosphorothioates,\n2&#x02032;deoxy-2&#x02032; fluorouridine, 2&#x02032;-O-methyl, 2&#x02032;-O-(2-methoxyethyl), and locked\nnucleotides\n[<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072225">31</a>&#x02013;<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072237">36</a>]. All of these chemically modified siRNAs were still able\nto induce siRNA-mediating gene silencing provided that the modifications\nwere absent in specific regions of the siRNA and included to a limited\nextent. These specific restrictions regarding position and degree of\nmodifications were dependent on the characteristics of the incorporated\nmodification. Although increased nuclease resistance of siRNA would be\nexpected to increase in vivo silencing effects, Layzer et al showed that\nthis is not necessarily the case. They studied silencing effects in the\nliver after hydrodynamic injection, and showed that unmodified siRNA had a\nsimilar potency as the stabilized version [<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072202">36</a>].</p><p id="__p14" class="p p-last">In contrast, chemical modifications were shown to enhance therapeutic\neffects in a mouse model of hepatitis B virus infection. Chemically modified\nsiRNA designed against a conserved region of the hepatitis B virus was shown\nto decrease viral DNA, hepatitis B surface antigen levels in serum, as well\nas viral RNA levels in liver over 1000-fold as compared to chemically\nmodified control siRNA and buffer-treated animals in a hydrodynamic\ninjection protocol. The benefit of chemically modified siRNA was supported\nby the fact that indicators of viral infection were 30-fold higher in\nanimals treated with unmodified siRNA [<a href="#B37" rid="B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072229">37</a>].</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Increasing intracellular uptake</h3><p id="__p15" class="p p-first">Several approaches have been developed where chemical modifications have\nbeen introduced to enhance intracellular uptake of siRNA. Liao and Wang developed poly-2&#x02032;-O-(2,4-dinitrophenyl) modified siRNA. The enhanced\nlipophilicity of this siRNA allows passive diffusion over the cell membrane,\nwhile at the same time enhancing nuclease resistance. This approach has only\nbeen investigated in vitro and shows that chemical modification can enhance\nsiRNA potency at both fronts. As a result the silencing effects of the\nchemically modified siRNA specific for insulin-like growth factor receptor\nwere strongly enhanced as compared to unmodified siRNA [<a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072211">38</a>].</p><p id="__p16">In a similar setup, membrane permeant peptides (penetratin and\ntransportin) were coupled to siRNA to facilitate their\nintracellular uptake. By coupling the peptide via a reducible\ndisulfide linker, the bulky peptides are expected to be\ncleaved-off liberating the siRNA in the cytoplasm. The approach\nwas validated in vitro, thus supporting wide application of the\nbasic technology. Nevertheless, cell specificity is lacking\n[<a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072246">39</a>].</p><p id="__p17">Probably the furthest developed work on chemically\nmodified siRNAs has been reported by Soutcheck et al\n[<a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072195">40</a>]. They have developed siRNAs with partial\nphosphorothioate backbone modifications and 2&#x02032;-O-methyl sugar\nvariations on the sense and antisense strands to promote nuclease\nresistance, while at the same time cholesterol was conjugated to\nthe 3&#x02032; end of the sense strand using a pyrrolidine linker to\nchange tissue distribution. The cholesterol-modified siRNA\nsilenced reporter gene expression in vitro in the absence of\ntransfection agents, something not observed for unmodified siRNAs.\nProbably the interaction of the cholesterol with serum components\nin the culture medium improved siRNA translocation over the\ncellular membrane. The cholesterol modification particularly\nenhanced binding of siRNA to serum albumin, probably explaining\nthe prolonged circulation half-life measured after intravenous\ninjection as compared to unmodified siRNA. In addition to a\nprolonged presence in the circulation, cholesterol-modified siRNAs\nwere detected in liver and jejunum at concentrations of\n100&#x02013;200 ng per gram tissue 24 hours after the last injection\nof 50 mg/kg doses. These levels were sufficient to reduce the\nlevels of the apolipoprotein apoB-100 in plasma by 31&#x02013;68%.\nThis reduction was paralleled by a 37% reduction in overall\ncholesterol levels, and reduction in high-density lipoprotein,\nlow- density lipoprotein, and chylomicron levels. Despite these\nimpressive results using relatively simple modifications, the\ndoses of chemically modified siRNAs needed are relatively high and\nseem to underline that changing tissue distribution of siRNA in\nfavor of target cell uptake by conjugation with comparatively\nsmall chemical groups is difficult to achieve. At the same time,\nsmall molecular weight modifications seem to be needed to preserve\ncorrect interaction with the RNAi enzymes. Cleavable linkers for\ncoupling of bulkier modifications may be an approach to avoid\nthese problems. In conclusion, chemical modifications do promise\nimportant advances regarding nuclease resistance and reduced\ninduction of the stress response. Invitrogen has developed a\nsecond-generation siRNA, known as Stealth RNAi, in which chemical\nmodifications are designed to increase the specificity of RNAi\neffects by allowing only the antisense strand to efficiently enter\nthe RNAi pathway and eliminating induction of interferon-related\npathways. Others have also demonstrated that sequence and\nmodifications can strongly influence intensity of silencing\nefficiency and inflammatory reactions, providing tools to optimize\nthese [<a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072209">41</a>, <a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072204">42</a>].</p><p id="__p18" class="p p-last">Taken together, chemical modifications can markedly increase\nnuclease resistance of siRNA improving cellular persistence and\nconjugation with translocating/hydrophobic functional groups can\nincrease membrane permeation. Strategies to affect\ntissue distribution profiles of siRNA with chemical modifications\nseem more difficult.</p></div></div><div id="__sec5" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec5title">VIRAL NUCLEIC ACID DELIVERY</h2><p id="__p19" class="p p-first">Viruses are at present the most efficient gene delivery vectors. After cell\nbinding they are capable of delivering their nucleic acid payload\nintracellularly in a proficient way along with nuclear localization.\nAlthough virus-mediated delivery methods are usually based on delivery of\ngenes encoding shRNA, few approaches used viruses to deliver chemically\nsynthesized siRNA in vivo [<a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072210">43</a>, <a href="#B44" rid="B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072213">44</a>].</p><div id="__sec6" class="sec"><h3 id="__sec6title">Delivery of chemically synthesized siRNA</h3><p id="__p20" class="p p-first-last">In this approach, reconstituted viral envelopes derived from influenza virus\nare used to encapsulate and deliver siRNAs. The reconstituted membrane\nvesicles contain the influenza virus spike protein hemagglutinin and\nadditionally added cationic lipids. This protein is responsible for binding\nto and fusion with cellular membranes. The siRNA-loaded vesicles are taken\nup by receptor-mediated endocytosis, and are able to escape endosomal\ndegradation by fusion with the endosomal membrane. Functional siRNA delivery\nwas demonstrated in vitro, while in vivo uptake by macrophages in the\nperitoneal cavity was demonstrated after intraperitoneal injection. A\nsimilar approach, described siRNA delivery by simian virus SV40-based\nparticles in vitro in lymphoblastoid cells [<a href="#B44" rid="B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072236">44</a>]. As\nwith many viral approaches, drawbacks of the systems are the difficulties of\nrepeated administration and limited control over transduced cell type.</p></div><div id="__sec7" class="sec"><h3 id="__sec7title">Delivery of DNA encoding siRNA/shRNA</h3><p id="__p21" class="p p-first">A number of studies investigated the use of DNA encoding for shRNA\ndelivered by viruses for gene silencing in vivo. Intravenous injection of \n5 &#x000d7; 10<sup>9</sup> plaque forming units (pfus) recombinant adenovirus expressing \nshRNA targeting hepatitis B virus transcripts in mice with active replication of\nthe hepatitis B virus, showed almost complete inhibition of viral protein production \n[<a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072251">45</a>]. This in turn led to arrest\nof viral replication at day 17 after viral infection. The\ninhibitory effect persisted for at least 10 days. Interestingly,\nthere appeared to be a fraction of viral protein that was not\nsusceptible to RNAi-mediated silencing, which is suggested to be\nattributable to protection through binding of their mRNA to\nspecific proteins. The exact nature of this protection and its\npossible involvement in RNAi resistance remains to be determined.</p><p id="__p22">Uchida et al used expression of two separate siRNA strands against survivin\nby adenoviral transduction to inhibit tumor growth. Survivin is a protein\nthat inhibits cancer cell apoptosis. Mice bearing subcutaneous U251 glioma\ntumors were treated with intratumoral injections of 10<sup>10</sup> viral\nparticles on three consecutive days every twenty days, ultimately leading to\nfour-fold smaller tumors at day 48 after start of treatment as compared to\nempty adenoviral vector and adenoviral vector expressing irrelevant siRNA\n[<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072248">20</a>].</p><p id="__p23">These studies demonstrate the possibilities for single intravenous or\nmultiple local injections of virally delivered DNA encoding si/shRNA for\ngene silencing. This strategy has been further confirmed in a number of\ndifferent in vivo models and with a number of different vectors, like\nintracranial delivery of lentivirus-produced shRNA for inhibition of\nreporter gene expression in cortical neurons [<a href="#B46" rid="B46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072207">46</a>],\nintraperitoneal delivery of lentivirus-produced shRNA for inhibition of\nviral cyclin to prevent primary effusion lymphoma in mice [<a href="#B47" rid="B47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072197">47</a>], intramuscular or intraspinal delivery of lentivirus-produced shRNA for\ninhibition of mutant SOD1 in amyotrophic lateral sclerosis\n[<a href="#B48" rid="B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_337483460">48</a>, <a href="#B49" rid="B49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_337483459">49</a>], and ex vivo delivery of lentivirus-produced shRNA for inhibition of CC-chemokine\nreceptor 2 in hematopoietic cells in mice [<a href="#B50" rid="B50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072196">50</a>].</p><p id="__p24">Taken together, the viral DNA-based sh/siRNA delivery process is very\nefficient: binding to the target cell surface and subsequent transduction,\ncarrier stability, and protection against nucleases appear satisfactory\n[<a href="#B51" rid="B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072221">51</a>&#x02013;<a href="#B54" rid="B54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072208">54</a>]. However, as the\ndiscussed approaches illustrate, viruses usually lack selectivity for the\ntarget cell type. To improve specificity, the natural tropism of viruses for\ncertain cell types may be used. Currently, much attention is focused on\nredirecting the natural preferred cell type of viruses towards\ntherapeutically interesting receptors on the surface of target cells.\nExamples include the retargeting of murine coronavirus to the human\nepidermal growth factor receptor [<a href="#B55" rid="B55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072239">55</a>], directing\nadenovirus via fibroblast growth factor ligand towards its associated\nreceptor (FGFR1) for delivery to glioma, or adenoviral delivery to\nangiogenic endothelium via RGD-peptides binding alpha v-integrins\n[<a href="#B56" rid="B56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_461986098">56</a>]. However, such approaches have not been tried as yet in combination with RNAi-mediated gene silencing in vivo.</p><p id="__p25" class="p">The strength of the viral delivery approach is the efficient transduction of\ncells. Challenges that remain are the control over transduced cell type,\nespecially after systemic administration. In addition, inflammatory\nreactions, immunogenicity, and oncogenic transformations continue to be\nimportant safety considerations for viral vectors that need to be addressed\n[<a href="#B57" rid="B57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072201">57</a>, <a href="#B58" rid="B58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072230">58</a>].</p><div id="__sec8" class="sec sec-last"><p></p><h4 id="__sec8title" class="inline">Nonviral nucleic acid delivery </h4><p id="__p26" class="p p-first">Whereas viral vectors possess many of the desired characteristics for\nefficient nucleic acid delivery, nonviral vectors possess several\nadvantages. Important benefits of synthetic vector systems are the safety\n(related to their lack of immunogenicity and low frequency of integration)\nand ease of large-scale production. In addition, they can accommodate a wide\nvariety of nucleic acid sizes and they allow easy modification. On the\ndownside, transfection efficiency can be a limiting factor.</p><p id="__p27" class="p p-last">To face this weakness, many functional groups need to be\nincorporated into nonviral nucleic acid delivery systems. A\ncationic functional group is usually required to bind and condense\nthe nucleic acid, thereby protecting it against nucleases and\n(important for siRNA) increasing the apparent molecular weight\nabove the renal clearance cut-off. In addition, some cationic\ncompounds are being used as endosomal escape enhancers.\nDue to the resulting positive charge, complexes tend to\nform aggregates by binding in the blood stream to negatively\ncharged biomolecules. As a result, their clearance is usually\nrapid. Moreover, such cationic complexes possess a propensity to\ninteract with virtually any cell type they encounter, creating a\nneed to insulate the interactive surface of the particle to\npromote specificity. For that purpose, shielding groups can be\nadded to enhance colloidal stability and reduce surface charge\nthereby avoiding nonspecific cell uptake. To restore cell\ninteraction in a target-specific manner targeting ligands can be\ncoupled to induce site-specific binding and uptake. In the case of\ndelivery of DNA encoding for shRNA by non-viral delivery\nsystems, nuclear translocation of the DNA is often inadequate. As\nsuch, the cytoplasmic site of activity of chemically synthesized\nsiRNA provides an important advantage.</p></div></div><div id="__sec9" class="sec"><h3 id="__sec9title">Delivery system based on RNA</h3><p id="__p28" class="p p-first-last">A system consisting completely of RNA was proposed by Guo et al\n[<a href="#B59" rid="B59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072232">59</a>]. Their system is based on the packaging RNA\nof the DNA-packaging motor of bacteriophage phi29, which can spontaneously\nform dimers via interlocking right- and left-hand loops. By attaching the\nsiRNA to one loop and an RNA aptamer to CD4 to the other, a cancer cell\ntargeted system was created that could silence survivin gene expression in\nvitro. Alternatively, the system could also be targeted by folate.</p></div><div id="__sec10" class="sec"><h3 id="__sec10title">Cationic delivery systems</h3><p id="__p29" class="p p-first">Unshielded, untargeted complexes of siRNA with cationic polymers or lipids,\ncan provide local or systemic transfection of a sufficient number of target\ncells for therapeutic effects. Several studies employed cationic lipids to\ncomplex siRNA to silence, amongst others,TNF-alpha in intraperitoneal\nmacrophages after intraperitoneal administration [<a href="#B60" rid="B60" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072238">60</a>], delta opioid receptor in spinal cord and dorsal root ganglia after intrathecal\nadministration [<a href="#B61" rid="B61" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072219">61</a>], polo-like kinase-1 in bladder\ncancer after intravesical administration, and c-raf-1 in prostate cancer\ncells after intravenous administration [<a href="#B62" rid="B62" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072199">62</a>]. Although, a sufficient number of cells must have been reached as silencing is observed,\nit is fair to assume that a large part of the dose will arrive in nontarget\ncells. In view of the nonspecific effects that can be induced by cationic\nlipids themselves and in particular in combination with dsRNA, this may\nseverely hamper therapeutic application [<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072235">25</a>, <a href="#B63" rid="B63" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072240">63</a>].</p><p id="__p30">A variety of other cationic compounds have also been investigated\nfor siRNA-delivery purposes. A linear low molecular weight form of\nthe cationic polymer poly(ethylene imine) (PEI) has been used for\ntreatment of (subcutaneously implanted) ovarian carcinoma in mice\n[<a href="#B64" rid="B64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072198">64</a>]. After intraperitoneal administration complexed siRNA was primarily recovered from muscle, liver, kidney, and tumor.\nInterestingly, the major organ where PEI nucleic acid-complexes\nare usually recovered, the lung, was largely avoided. Importantly,\nsilencing of Her-2 with these polyplexes inhibited ovarian\ncarcinoma growth in vivo.</p><p id="__p31" class="p p-last">Atelocollagen (a highly purified type-I collagen of calf dermis\ndigested by pepsin), was shown to be a suitable vehicle for local\ndelivery of siRNA [<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072241">17</a>, <a href="#B65" rid="B65" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072216">65</a>]. In addition, when administered\nintravenously, atelocollagen-siRNA was able to localize at sites\nof tumor mestastases and inhibit metastasis outgrowth [<a href="#B66" rid="B66" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072244">66</a>].\nMore specifically, tumor levels increased \n&#x0223c; 6-fold as\ncompared to levels after &#x0201c;naked&#x0201d; siRNA administration (from 0.7\nto 4.3 ng/mg after injection of 25 &#x003bc;g siRNA). This\neffect was, albeit less pronounced, also seen in the other organs\ninvestigated (ie, liver, lungs, kidneys, and spleen) demonstrating\nthat the enhanced tissue uptake is not exclusively tumor-specific.\nNevertheless, delivery of these levels of siRNA silencing EZH2\n(enhancer of zest homologue-2, a gene overexpressed in\nhormone-refractory metastatic prostate cancer) or \np110-&#x003b1; (a phosphatidylinositol 3-kinase regulating cell survival, proliferation, and migration) \nresulted in strong inhibition of growth of bone metastases of prostate cancer cells. \nImportantly, siRNA-atelocollagen complexes failed to induce\nnonspecific proinflammatory responses like secretion of\nIFN-&#x003b1; and IL-12.</p></div><div id="__sec11" class="sec"><h3 id="__sec11title">Targeted cationic delivery systems</h3><p id="__p32" class="p p-first">A targeted amino-acid-based system was based on the cationic\npeptide protamine [<a href="#B67" rid="B67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_337483456">67</a>]. \nTo the system\'s protamine-block the C-terminus of the heavy chain Fab \nfragment of an HIV-1 envelope antibody was coupled to form a protein construct known \nas F105-P. This system was highly efficient in binding to and transfection of\ncells expressing HIV-envelope protein, although it is unclear why\nthe HIV-envelope protein would be internalized. Importantly,\nexpression of interferon-&#x003b2;, 2&#x02032;, 5&#x02032;-oligoadenylate\nsynthetase, and Stat-1, as indicators of  nonspecific\neffects, were not increased upon siRNA transfection of\nHIV-envelope-expressing melanoma cells. In addition, when these\ncells formed subcutaneous tumors in vivo, 30% of cells took up\nfluorescent siRNA when delivered by F105-P after intravenous\nadministration. Naked siRNA was not taken up, nor was F105-P-siRNA\ndelivered to cells that were envelope-protein negative. Delivery\nof a combination of siRNAs against c-myc, MDM2, VEGF strongly\ninhibited tumor growth in vivo when delivered using the F105-P\nsystem. This combination of siRNAs attacking the tumor\nat multiple fronts is an important advantage of the siRNA\ntechnology as it allows simultaneous interference with a number of\ndifferent pathways, while the delivery problem for each individual\ndrug molecule (siRNA) remains the same. The versatility of this\ntargeted system was demonstrated by exchanging the HIV-envelope\nantibody for an ErbB2-antibody changing the specificity of the\nsystem to ErbB2-positive breast carcinoma cells.</p><p id="__p33" class="p p-last">In a cationic lipid-based approach, Pirollo et al coupled a\ntransferrin receptor single chain Fv region antibody fragment to\nthe surface of cationic DOTAP: DOPE complexes containing siRNA\n[<a href="#B68" rid="B68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072252">68</a>]. They evaluated the \ntargeting potential of these systems in different murine tumor models: \nan orthothopically implanted\npancreatic carcinoma (that produced spontaneous metastases), an\northotopically implanted prostate carcinoma, and intravenously\nadministered breast carcinoma cells giving rise to metastases in\nthe lung. In all these models, specific accumulation of\nfluorescently labeled siRNA complexed to the targeted cationic\nlipid particles at the site of the malignancy could be\ndemonstrated as compared to surrounding normal tissue and liver.\nThe question whether targeted delivery resulted in gene silencing\nwas not addressed.</p></div><div id="__sec12" class="sec sec-last"><h3 id="__sec12title">Shielded targeted cationic delivery systems</h3><p id="__p34" class="p p-first">Targeted cationic systems have the important advantage that they possess a\nrecognition signal for specific interaction with the target cell type.\nHowever, the cationic surface may also be able to interact with biomolecules\nor nontarget cells. As such, shielding of the cationic surface may further\nenhance target cell specificity by reducing nontarget tissue uptake and may\nadditionally increase colloidal stability of the siRNA complexes.</p><p id="__p35">In our studies we focused on the cationic polymer PEI coupled to\nPEG as shielding polymer. To the distal end of the\nPEG-chain a cyclic RGD-peptide was coupled. This peptide is a\nhigh-affinity ligand for alpha v-integrins that are overexpressed\non angiogenic endothelial surfaces [<a href="#B69" rid="B69" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072249">69</a>]. \nTissue distribution studies in vivo of fluorescently labeled siRNA in subcutaneous\nneuroblastoma-bearing mice showed that injection of &#x0201c;naked&#x0201d;\nsiRNA did not produce appreciable tumor levels, but rather rapid\nclearance into the urine. PEI-siRNA complexes also lacked the\nproduction of high fluorescence in the tumor, but did increase\nliver and especially lung levels. The fluorescence appeared\npunctuate in both latter tissues, probably reflecting formation of\naggregates in the circulation.</p><p id="__p36">When the PEG-shielded, targeted nanoparticles were used, a\nhigher level of specificity for the tumor and lower levels of\nfluorescence in the lung and liver were observed.\nIn a therapeutic setting, siRNA against murine VEGF\nreceptor-2 was used, since the receptor is one of the driving\nfactors of tumor angiogenesis. Delivery to host tumor endothelium\nis required to inhibit tumor proliferation. Efficacy studies with\nVEGFR2-specific siRNA complexed in RGD-PEG-PEI nanoparticles\nresulted in strong inhibition of sc neuroblastoma growth rate,\nwhich was sequence-specific. These experiments suggest that the\ntargeted shielded nanoparticles indeed deliver the siRNA to the\nangiogenic endothelial cells. In line with these findings, the\nreduced tumor growth rate was paralleled by a reduction in blood\nvessels in the periphery of the tumor and changes in vascular\nmorphology of remaining vessels, supporting an antiangiogenic\nmechanism of action. These results were supported by studies in a\nmodel of pathological angiogenesis in the eye [<a href="#B70" rid="B70" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072231">70</a>], \nagain demonstrating vasculature-specific delivery and inhibition of\nangiogenesis leading to therapeutic effects. Importantly, the\nstudies in the eye also showed that combining siRNAs against\ndifferent driving factors in the VEGF-pathway in the same delivery\nsystem improved therapeutic effects. Attacking the various\nreceptors and growth factors simultaneously seems to\noffer advantages. Especially in multifactorial diseases, where\nfunctional redundancy is likely, this cocktail approach seems to\noffer important benefits.</p><p id="__p37" class="p p-last">Synthetic nonviral delivery systems are a diverse class of molecules used in\ndifferent nucleic acid delivery strategies that range from relatively simple\ncationic complexation for local administration to targeted shielded systems\nfor intravenous injection. Their adaptability to specific targeting\nrequirements is an important advantage, although optimization of delivery\nefficiency continues to remain important.</p></div></div><div id="__sec13" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec13title">FINAL REMARKS</h2><p id="__p38" class="p p-first-last">Over the last decades, research on the promises of nucleic acids\nfor therapeutic intervention and the difficulties encountered in\nturning these promises into clinical reality has provided a\nclearer picture of the development steps that are needed to\ntransform nucleic acids into actual drug molecules. As a result \nsiRNA has been able to make a remarkable rapid\nprogress from initial discovery as functional mediator of RNA\ninterference in mammalian cells in 2001 to three\nclinical trials at the end of 2005: two in age-related macular\ndegeneration, the other in respiratory syncytial virus infection\n[<a href="#B71" rid="B71" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_125072227">71</a>]. Nevertheless, the \nchoice of the diseases also reflects the delivery difficulties encountered \nfor this class of nucleic acids. These diseases were selected partly because the target cell\ndelivery problems are relatively low as these pathologies are\nconfined to specific and accessible sites. To further improve\ntarget specificity, also in view of possible adverse effects\noccurring when siRNA is processed by nontarget cells, and to allow\napplication of siRNA for systemic treatment several strategies can\nbe proposed (<a href="/pmc/articles/PMC1559924/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). Taken together they serve to\nincrease nuclease resistance, to reduce renal\nexcretion/specific cell uptake, to promote uptake by the\ntarget cells, and to ensure correct intracellular trafficking to\nthe site of action. As the first preclinical proofs of principle\nhave been delivered showing therapeutic effects of locally and\nsystemically delivered siRNAs, it is expected that these\nstrategies will soon translate into viable clinical development\nprograms.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC1559924/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139967515814816" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1559924_JBB2006-63675.002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is JBB2006-63675.002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1559924/bin/JBB2006-63675.002.jpg" /></a></div><div id="largeobj_idm139967515814816" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1559924/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC1559924/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p40">Strategies for siRNA delivery. Strategies are based on\n(a) chemical modifications of siRNA, (b) targeting of siRNA using viral\nvectors, or (c) nonviral delivery systems.</p></div></div></div></div><div id="idm139967552623280" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139967552623280title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="citation">Sontheimer EJ, Carthew RW. Silence from within: endogenous siRNAs and miRNAs. <span><span class="ref-journal"><em>Cell</em>. </span>2005;<span class="ref-vol">122</span>(1):9\xe2\x80\x9312.</span> [<a href="/pubmed/16009127" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Silence+from+within:+endogenous+siRNAs+and+miRNAs&amp;author=EJ+Sontheimer&amp;author=RW+Carthew&amp;volume=122&amp;issue=1&amp;publication_year=2005&amp;pages=9-12&amp;pmid=16009127&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="citation">Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. <span><span class="ref-journal"><em>Science</em>. </span>2005;<span class="ref-vol">309</span>(5740):1519\xe2\x80\x931524.</span> [<a href="/pubmed/16141061" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Ribo-gnome:+the+big+world+of+small+RNAs&amp;author=PD+Zamore&amp;author=B+Haley&amp;volume=309&amp;issue=5740&amp;publication_year=2005&amp;pages=1519-1524&amp;pmid=16141061&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="citation">Sioud M. On the delivery of small interfering RNAs into mammalian cells. <span><span class="ref-journal"><em>Expert Opinion on Drug Delivery</em>. </span>2005;<span class="ref-vol">2</span>(4):639\xe2\x80\x93651.</span> [<a href="/pubmed/16296791" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opinion+on+Drug+Delivery&amp;title=On+the+delivery+of+small+interfering+RNAs+into+mammalian+cells&amp;author=M+Sioud&amp;volume=2&amp;issue=4&amp;publication_year=2005&amp;pages=639-651&amp;pmid=16296791&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="citation">Lu PY, Xie F, Woodle MC. In vivo application of RNA interference: from functional genomics to therapeutics. <span><span class="ref-journal"><em>Advances in Genetics</em>. </span>2005;<span class="ref-vol">54</span>:117\xe2\x80\x93142.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112075/">PMC free article</a>]</span> [<a href="/pubmed/16096010" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Advances+in+Genetics&amp;title=In+vivo+application+of+RNA+interference:+from+functional+genomics+to+therapeutics&amp;author=PY+Lu&amp;author=F+Xie&amp;author=MC+Woodle&amp;volume=54&amp;publication_year=2005&amp;pages=117-142&amp;pmid=16096010&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="citation">Schiffelers RM, Woodle MC, Scaria PV. Pharmaceutical prospects for RNA interference. <span><span class="ref-journal"><em>Pharmaceutical Research</em>. </span>2004;<span class="ref-vol">21</span>(1):1\xe2\x80\x937.</span> [<a href="/pubmed/14984251" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceutical+Research&amp;title=Pharmaceutical+prospects+for+RNA+interference&amp;author=RM+Schiffelers&amp;author=MC+Woodle&amp;author=PV+Scaria&amp;volume=21&amp;issue=1&amp;publication_year=2004&amp;pages=1-7&amp;pmid=14984251&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="citation">Chiu YL, Ali A, Chu CY, Cao H, Rana TM. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. <span><span class="ref-journal"><em>Chemistry &#x00026; Biology</em>. </span>2004;<span class="ref-vol">11</span>(8):1165\xe2\x80\x931175.</span> [<a href="/pubmed/15324818" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chemistry+&#x00026;+Biology&amp;title=Visualizing+a+correlation+between+siRNA+localization,+cellular+uptake,+and+RNAi+in+living+cells&amp;author=YL+Chiu&amp;author=A+Ali&amp;author=CY+Chu&amp;author=H+Cao&amp;author=TM+Rana&amp;volume=11&amp;issue=8&amp;publication_year=2004&amp;pages=1165-1175&amp;pmid=15324818&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="citation">Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. <span><span class="ref-journal"><em>Nature Cell Biology</em>. </span>2005;<span class="ref-vol">7</span>(7):719\xe2\x80\x93723.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1855297/">PMC free article</a>]</span> [<a href="/pubmed/15937477" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Cell+Biology&amp;title=MicroRNA-dependent+localization+of+targeted+mRNAs+to+mammalian+P-bodies&amp;author=J+Liu&amp;author=MA+Valencia-Sanchez&amp;author=GJ+Hannon&amp;author=R+Parker&amp;volume=7&amp;issue=7&amp;publication_year=2005&amp;pages=719-723&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="citation">Sen GL, Blau HM. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. <span><span class="ref-journal"><em>Nature Cell Biology</em>. </span>2005;<span class="ref-vol">7</span>(6):633\xe2\x80\x93636.</span> [<a href="/pubmed/15908945" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Cell+Biology&amp;title=Argonaute+2/RISC+resides+in+sites+of+mammalian+mRNA+decay+known+as+cytoplasmic+bodies&amp;author=GL+Sen&amp;author=HM+Blau&amp;volume=7&amp;issue=6&amp;publication_year=2005&amp;pages=633-636&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="citation">Robb GB, Brown KM, Khurana J, Rana TM. Specific and potent RNAi in the nucleus of human cells. <span><span class="ref-journal"><em>Nature Structural &#x00026; Molecular Biology</em>. </span>2005;<span class="ref-vol">12</span>(2):133\xe2\x80\x93137.</span> [<a href="/pubmed/15643423" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Structural+&#x00026;+Molecular+Biology&amp;title=Specific+and+potent+RNAi+in+the+nucleus+of+human+cells&amp;author=GB+Robb&amp;author=KM+Brown&amp;author=J+Khurana&amp;author=TM+Rana&amp;volume=12&amp;issue=2&amp;publication_year=2005&amp;pages=133-137&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="citation">Duxbury MS, Matros E, Ito H, Zinner MJ, Ashley SW, Whang EE. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. <span><span class="ref-journal"><em>Annals of Surgery</em>. </span>2004;<span class="ref-vol">240</span>(4):667\xe2\x80\x93674.</span> discussion 675&#x02013;676. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1356468/">PMC free article</a>]</span> [<a href="/pubmed/15383794" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+Surgery&amp;title=Systemic+siRNA-mediated+gene+silencing:+a+new+approach+to+targeted+therapy+of+cancer&amp;author=MS+Duxbury&amp;author=E+Matros&amp;author=H+Ito&amp;author=MJ+Zinner&amp;author=SW+Ashley&amp;volume=240&amp;issue=4&amp;publication_year=2004&amp;pages=667-674&amp;pmid=15383794&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="citation">Feinberg EH, Hunter CP. Transport of dsRNA into cells by the transmembrane protein SID-1. <span><span class="ref-journal"><em>Science</em>. </span>2003;<span class="ref-vol">301</span>(5639):1545\xe2\x80\x931547.</span> [<a href="/pubmed/12970568" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Transport+of+dsRNA+into+cells+by+the+transmembrane+protein+SID-1&amp;author=EH+Feinberg&amp;author=CP+Hunter&amp;volume=301&amp;issue=5639&amp;publication_year=2003&amp;pages=1545-1547&amp;pmid=12970568&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="citation">Duxbury MS, Ashley SW, Whang EE. RNA interference: a mammalian SID-1 homologue enhances siRNA uptake and gene \nsilencing efficacy in human cells. <span><span class="ref-journal"><em>Biochemical and Biophysical Research Communications</em>. </span>2005;<span class="ref-vol">331</span>(2):459\xe2\x80\x93463.</span> [<a href="/pubmed/15850781" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical+and+Biophysical+Research+Communications&amp;title=RNA+interference:+a+mammalian+SID-1+homologue+enhances+siRNA+uptake+and+gene+&#10;silencing+efficacy+in+human+cells&amp;author=MS+Duxbury&amp;author=SW+Ashley&amp;author=EE+Whang&amp;volume=331&amp;issue=2&amp;publication_year=2005&amp;pages=459-463&amp;pmid=15850781&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="citation">Hamar P, Song E, Kokeny G, Chen A, Ouyang N, Lieberman J. Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. <span><span class="ref-journal"><em>Proceedings of the National Academy of Sciences of the United States of America</em>. </span>2004;<span class="ref-vol">101</span>(41):14883\xe2\x80\x9314888.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC522049/">PMC free article</a>]</span> [<a href="/pubmed/15466709" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;title=Small+interfering+RNA+targeting+Fas+protects+mice+against+renal+ischemia-reperfusion+injury&amp;author=P+Hamar&amp;author=E+Song&amp;author=G+Kokeny&amp;author=A+Chen&amp;author=N+Ouyang&amp;volume=101&amp;issue=41&amp;publication_year=2004&amp;pages=14883-14888&amp;pmid=15466709&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="citation">Chae SS, Paik JH, Furneaux H, Hla T. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis \ndemonstrated by in vivo RNA interference. <span><span class="ref-journal"><em>The Journal of Clinical Investigation</em>. </span>2004;<span class="ref-vol">114</span>(8):1082\xe2\x80\x931089.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC522258/">PMC free article</a>]</span> [<a href="/pubmed/15489955" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of+Clinical+Investigation&amp;title=Requirement+for+sphingosine+1-phosphate+receptor-1+in+tumor+angiogenesis+&#10;demonstrated+by+in+vivo+RNA+interference&amp;author=SS+Chae&amp;author=JH+Paik&amp;author=H+Furneaux&amp;author=T+Hla&amp;volume=114&amp;issue=8&amp;publication_year=2004&amp;pages=1082-1089&amp;pmid=15489955&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="citation">Akaneya Y, Jiang B, Tsumoto T. RNAi-induced gene silencing by local electroporation in targeting brain region. <span><span class="ref-journal"><em>Journal of Neurophysiology</em>. </span>2005;<span class="ref-vol">93</span>(1):594\xe2\x80\x93602.</span> [<a href="/pubmed/15604463" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Neurophysiology&amp;title=RNAi-induced+gene+silencing+by+local+electroporation+in+targeting+brain+region&amp;author=Y+Akaneya&amp;author=B+Jiang&amp;author=T+Tsumoto&amp;volume=93&amp;issue=1&amp;publication_year=2005&amp;pages=594-602&amp;pmid=15604463&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="citation">Schiffelers RM, Xu J, Storm G, Woodle MC, Scaria PV. Effects of treatment with small interfering RNA on joint inflammation in mice with \ncollagen-induced arthritis. <span><span class="ref-journal"><em>Arthritis and Rheumatism</em>. </span>2005;<span class="ref-vol">52</span>(4):1314\xe2\x80\x931318.</span> [<a href="/pubmed/15818667" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+and+Rheumatism&amp;title=Effects+of+treatment+with+small+interfering+RNA+on+joint+inflammation+in+mice+with+&#10;collagen-induced+arthritis&amp;author=RM+Schiffelers&amp;author=J+Xu&amp;author=G+Storm&amp;author=MC+Woodle&amp;author=PV+Scaria&amp;volume=52&amp;issue=4&amp;publication_year=2005&amp;pages=1314-1318&amp;pmid=15818667&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="citation">Minakuchi Y, Takeshita F, Kosaka N, et al.  Atelocollagenmediated synthetic small interfering RNA delivery for effective gene \nsilencing in vitro and in vivo. <span><span class="ref-journal"><em>Nucleic Acids Research</em>. </span>2004;<span class="ref-vol">32</span>(13):e109.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC506824/">PMC free article</a>]</span> [<a href="/pubmed/15272050" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Research&amp;title=Atelocollagenmediated+synthetic+small+interfering+RNA+delivery+for+effective+gene+&#10;silencing+in+vitro+and+in+vivo&amp;author=Y+Minakuchi&amp;author=F+Takeshita&amp;author=N+Kosaka&amp;volume=32&amp;issue=13&amp;publication_year=2004&amp;pages=e109&amp;pmid=15272050&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="citation">Leng Q, Mixson AJ. Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo. <span><span class="ref-journal"><em>Cancer Gene Therapy</em>. </span>2005;<span class="ref-vol">12</span>(8):682\xe2\x80\x93690.</span> [<a href="/pubmed/15803144" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Gene+Therapy&amp;title=Small+interfering+RNA+targeting+Raf-1+inhibits+tumor+growth+in+vitro+and+in+vivo&amp;author=Q+Leng&amp;author=AJ+Mixson&amp;volume=12&amp;issue=8&amp;publication_year=2005&amp;pages=682-690&amp;pmid=15803144&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="citation">Tsunoda S, Mazda O, Oda Y, et al.  Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. <span><span class="ref-journal"><em>Biochemical and Biophysical Research Communications</em>. </span>2005;<span class="ref-vol">336</span>(1):118\xe2\x80\x93127.</span> [<a href="/pubmed/16125678" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical+and+Biophysical+Research+Communications&amp;title=Sonoporation+using+microbubble+BR14+promotes+pDNA/siRNA+transduction+to+murine+heart&amp;author=S+Tsunoda&amp;author=O+Mazda&amp;author=Y+Oda&amp;volume=336&amp;issue=1&amp;publication_year=2005&amp;pages=118-127&amp;pmid=16125678&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="citation">Uchida H, Tanaka T, Sasaki K, et al.  Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated \ntumor cell growth in vitro and in vivo. <span><span class="ref-journal"><em>Molecular Therapy</em>. </span>2004;<span class="ref-vol">10</span>(1):162\xe2\x80\x93171.</span> [<a href="/pubmed/15233951" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+Therapy&amp;title=Adenovirus-mediated+transfer+of+siRNA+against+survivin+induced+apoptosis+and+attenuated+&#10;tumor+cell+growth+in+vitro+and+in+vivo&amp;author=H+Uchida&amp;author=T+Tanaka&amp;author=K+Sasaki&amp;volume=10&amp;issue=1&amp;publication_year=2004&amp;pages=162-171&amp;pmid=15233951&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="citation">Sumimoto H, Yamagata S, Shimizu A, et al.  Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally \nmediated RNA interference. <span><span class="ref-journal"><em>Gene Therapy</em>. </span>2005;<span class="ref-vol">12</span>(1):95\xe2\x80\x93100.</span> [<a href="/pubmed/15385954" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Therapy&amp;title=Gene+therapy+for+human+small-cell+lung+carcinoma+by+inactivation+of+Skp-2+with+virally+&#10;mediated+RNA+interference&amp;author=H+Sumimoto&amp;author=S+Yamagata&amp;author=A+Shimizu&amp;volume=12&amp;issue=1&amp;publication_year=2005&amp;pages=95-100&amp;pmid=15385954&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="citation">Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. Activation of the interferon system by short-interfering RNAs. <span><span class="ref-journal"><em>Nature Cell Biology</em>. </span>2003;<span class="ref-vol">5</span>(9):834\xe2\x80\x93839.</span> [<a href="/pubmed/12942087" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Cell+Biology&amp;title=Activation+of+the+interferon+system+by+short-interfering+RNAs&amp;author=CA+Sledz&amp;author=M+Holko&amp;author=MJ+de+Veer&amp;author=RH+Silverman&amp;author=BR+Williams&amp;volume=5&amp;issue=9&amp;publication_year=2003&amp;pages=834-839&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="citation">Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded \nand single-stranded siRNAs is sequence-dependent and requires endosomal localization. <span><span class="ref-journal"><em>Journal of Molecular Biology</em>. </span>2005;<span class="ref-vol">348</span>(5):1079\xe2\x80\x931090.</span> [<a href="/pubmed/15854645" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Molecular+Biology&amp;title=Induction+of+inflammatory+cytokines+and+interferon+responses+by+double-stranded+&#10;and+single-stranded+siRNAs+is+sequence-dependent+and+requires+endosomal+localization&amp;author=M+Sioud&amp;volume=348&amp;issue=5&amp;publication_year=2005&amp;pages=1079-1090&amp;pmid=15854645&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="citation">Hornung V, Guenthner-Biller M, Bourquin C, et al.  Sequencespecific potent induction of IFN-alpha by short interfering RNA in plasmacytoid \ndendritic cells through TLR7. <span><span class="ref-journal"><em>Nature Medicine</em>. </span>2005;<span class="ref-vol">11</span>(3):263\xe2\x80\x93270.</span> [<a href="/pubmed/15723075" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Medicine&amp;title=Sequencespecific+potent+induction+of+IFN-alpha+by+short+interfering+RNA+in+plasmacytoid+&#10;dendritic+cells+through+TLR7&amp;author=V+Hornung&amp;author=M+Guenthner-Biller&amp;author=C+Bourquin&amp;volume=11&amp;issue=3&amp;publication_year=2005&amp;pages=263-270&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="citation">Ma Z, Li J, He F, Wilson A, Pitt B, Li S. Cationic lipids enhance siRNA-mediated interferon response in mice. <span><span class="ref-journal"><em>Biochemical and Biophysical Research Communications</em>. </span>2005;<span class="ref-vol">330</span>(3):755\xe2\x80\x93759.</span> [<a href="/pubmed/15809061" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical+and+Biophysical+Research+Communications&amp;title=Cationic+lipids+enhance+siRNA-mediated+interferon+response+in+mice&amp;author=Z+Ma&amp;author=J+Li&amp;author=F+He&amp;author=A+Wilson&amp;author=B+Pitt&amp;volume=330&amp;issue=3&amp;publication_year=2005&amp;pages=755-759&amp;pmid=15809061&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="citation">Manoharan M. RNA interference and chemically modified small interfering RNAs. <span><span class="ref-journal"><em>Current Opinion in Chemical Biology</em>. </span>2004;<span class="ref-vol">8</span>(6):570\xe2\x80\x93579.</span> [<a href="/pubmed/15556399" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Current+Opinion+in+Chemical+Biology&amp;title=RNA+interference+and+chemically+modified+small+interfering+RNAs&amp;author=M+Manoharan&amp;volume=8&amp;issue=6&amp;publication_year=2004&amp;pages=570-579&amp;pmid=15556399&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="citation">Verma S, Jager S, Thum O, Famulok M. Functional tuning of nucleic acids by chemical modifications: tailored oligonucleotides as \ndrugs, devices, and diagnostics. <span><span class="ref-journal"><em>The Chemical Record</em>. </span>2003;<span class="ref-vol">3</span>(1):51\xe2\x80\x9360.</span> [<a href="/pubmed/12552531" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Chemical+Record&amp;title=Functional+tuning+of+nucleic+acids+by+chemical+modifications:+tailored+oligonucleotides+as+&#10;drugs,+devices,+and+diagnostics&amp;author=S+Verma&amp;author=S+Jager&amp;author=O+Thum&amp;author=M+Famulok&amp;volume=3&amp;issue=1&amp;publication_year=2003&amp;pages=51-60&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="citation">Kurreck J. Antisense technologies. Improvement through novel chemical modifications. <span><span class="ref-journal"><em>European Journal of Biochemistry</em>. </span>2003;<span class="ref-vol">270</span>(8):1628\xe2\x80\x931644.</span> [<a href="/pubmed/12694176" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=European+Journal+of+Biochemistry&amp;title=Antisense+technologies.+Improvement+through+novel+chemical+modifications&amp;author=J+Kurreck&amp;volume=270&amp;issue=8&amp;publication_year=2003&amp;pages=1628-1644&amp;pmid=12694176&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="citation">Chiu YL, Rana TM. siRNA function in RNAi: a chemical modification analysis. <span><span class="ref-journal"><em>RNA</em>. </span>2003;<span class="ref-vol">9</span>(9):1034\xe2\x80\x931048.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1370469/">PMC free article</a>]</span> [<a href="/pubmed/12923253" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=RNA&amp;title=siRNA+function+in+RNAi:+a+chemical+modification+analysis&amp;author=YL+Chiu&amp;author=TM+Rana&amp;volume=9&amp;issue=9&amp;publication_year=2003&amp;pages=1034-1048&amp;pmid=12923253&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="citation">Hall AH, Wan J, Shaughnessy EE, Ramsay Shaw B, Alexander KA. RNA interference using boranophosphate siRNAs: structure-activity relationships. <span><span class="ref-journal"><em>Nucleic Acids Research</em>. </span>2004;<span class="ref-vol">32</span>(20):5991\xe2\x80\x936000.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC534620/">PMC free article</a>]</span> [<a href="/pubmed/15545637" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Research&amp;title=RNA+interference+using+boranophosphate+siRNAs:+structure-activity+relationships&amp;author=AH+Hall&amp;author=J+Wan&amp;author=EE+Shaughnessy&amp;author=B+Ramsay+Shaw&amp;author=KA+Alexander&amp;volume=32&amp;issue=20&amp;publication_year=2004&amp;pages=5991-6000&amp;pmid=15545637&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="citation">Braasch DA, Jensen S, Liu Y, et al.  RNA interference in mammalian cells by chemically-modified RNA. <span><span class="ref-journal"><em>Biochemistry</em>. </span>2003;<span class="ref-vol">42</span>(26):7967\xe2\x80\x937975.</span> [<a href="/pubmed/12834349" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=RNA+interference+in+mammalian+cells+by+chemically-modified+RNA&amp;author=DA+Braasch&amp;author=S+Jensen&amp;author=Y+Liu&amp;volume=42&amp;issue=26&amp;publication_year=2003&amp;pages=7967-7975&amp;pmid=12834349&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="citation">Czauderna F, Fechtner M, Dames S, et al.  Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. <span><span class="ref-journal"><em>Nucleic Acids Research</em>. </span>2003;<span class="ref-vol">31</span>(11):2705\xe2\x80\x932716.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC156727/">PMC free article</a>]</span> [<a href="/pubmed/12771196" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Research&amp;title=Structural+variations+and+stabilising+modifications+of+synthetic+siRNAs+in+mammalian+cells&amp;author=F+Czauderna&amp;author=M+Fechtner&amp;author=S+Dames&amp;volume=31&amp;issue=11&amp;publication_year=2003&amp;pages=2705-2716&amp;pmid=12771196&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="citation">Hoshika S, Minakawa N, Kamiya H, Harashima H, Matsuda A. RNA interference induced by siRNAs modified with 4&#x02032;-thioribonucleosides in cultured mammalian cells. <span><span class="ref-journal"><em>FEBS Letters</em>. </span>2005;<span class="ref-vol">579</span>(14):3115\xe2\x80\x933118.</span> [<a href="/pubmed/15919084" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Letters&amp;title=RNA+interference+induced+by+siRNAs+modified+with+4&#x02032;-thioribonucleosides+in+cultured+mammalian+cells&amp;author=S+Hoshika&amp;author=N+Minakawa&amp;author=H+Kamiya&amp;author=H+Harashima&amp;author=A+Matsuda&amp;volume=579&amp;issue=14&amp;publication_year=2005&amp;pages=3115-3118&amp;pmid=15919084&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="citation">Harborth J, Elbashir SM, Vandenburgh K, et al.  Sequence, chemical, and structural variation of small interfering RNAs and short hairpin \nRNAs and the effect on mammalian gene silencing. <span><span class="ref-journal"><em>Antisense &#x00026; Nucleic Acid Drug Development</em>. </span>2003;<span class="ref-vol">13</span>(2):83\xe2\x80\x93105.</span> [<a href="/pubmed/12804036" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antisense+&#x00026;+Nucleic+Acid+Drug+Development&amp;title=Sequence,+chemical,+and+structural+variation+of+small+interfering+RNAs+and+short+hairpin+&#10;RNAs+and+the+effect+on+mammalian+gene+silencing&amp;author=J+Harborth&amp;author=SM+Elbashir&amp;author=K+Vandenburgh&amp;volume=13&amp;issue=2&amp;publication_year=2003&amp;pages=83-105&amp;pmid=12804036&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="citation">Prakash TP, Allerson CR, Dande P, et al.  Positional effect of chemical modifications on short interference RNA activity in mammalian cells. <span><span class="ref-journal"><em>Journal of Medicinal Chemistry</em>. </span>2005;<span class="ref-vol">48</span>(13):4247\xe2\x80\x934253.</span> [<a href="/pubmed/15974578" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Medicinal+Chemistry&amp;title=Positional+effect+of+chemical+modifications+on+short+interference+RNA+activity+in+mammalian+cells&amp;author=TP+Prakash&amp;author=CR+Allerson&amp;author=P+Dande&amp;volume=48&amp;issue=13&amp;publication_year=2005&amp;pages=4247-4253&amp;pmid=15974578&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="citation">Layzer JM, McCaffrey AP, Tanner AK, Huang Z, Kay MA, Sullenger BA. In vivo activity of nuclease-resistant siRNAs. <span><span class="ref-journal"><em>RNA</em>. </span>2004;<span class="ref-vol">10</span>(5):766\xe2\x80\x93771.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1370566/">PMC free article</a>]</span> [<a href="/pubmed/15100431" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=RNA&amp;title=In+vivo+activity+of+nuclease-resistant+siRNAs&amp;author=JM+Layzer&amp;author=AP+McCaffrey&amp;author=AK+Tanner&amp;author=Z+Huang&amp;author=MA+Kay&amp;volume=10&amp;issue=5&amp;publication_year=2004&amp;pages=766-771&amp;pmid=15100431&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="citation">Morrissey DV, Blanchard K, Shaw L, et al.  Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. <span><span class="ref-journal"><em>Hepatology</em>. </span>2005;<span class="ref-vol">41</span>(6):1349\xe2\x80\x931356.</span> [<a href="/pubmed/15880588" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Activity+of+stabilized+short+interfering+RNA+in+a+mouse+model+of+hepatitis+B+virus+replication&amp;author=DV+Morrissey&amp;author=K+Blanchard&amp;author=L+Shaw&amp;volume=41&amp;issue=6&amp;publication_year=2005&amp;pages=1349-1356&amp;pmid=15880588&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="citation">Liao H, Wang JH. Biomembrane-permeable and ribonuclease-resistant siRNA with enhanced activity. <span><span class="ref-journal"><em>Oligonucleotides</em>. </span>2005;<span class="ref-vol">15</span>(3):196\xe2\x80\x93205.</span> [<a href="/pubmed/16201907" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oligonucleotides&amp;title=Biomembrane-permeable+and+ribonuclease-resistant+siRNA+with+enhanced+activity&amp;author=H+Liao&amp;author=JH+Wang&amp;volume=15&amp;issue=3&amp;publication_year=2005&amp;pages=196-205&amp;pmid=16201907&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="citation">Muratovska A, Eccles MR. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. <span><span class="ref-journal"><em>FEBS Letters</em>. </span>2004;<span class="ref-vol">558</span>(1&#x02013;3):63\xe2\x80\x9368.</span> [<a href="/pubmed/14759517" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Letters&amp;title=Conjugate+for+efficient+delivery+of+short+interfering+RNA+(siRNA)+into+mammalian+cells&amp;author=A+Muratovska&amp;author=MR+Eccles&amp;volume=558&amp;issue=1&#x02013;3&amp;publication_year=2004&amp;pages=63-68&amp;pmid=14759517&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="citation">Soutschek J, Akinc A, Bramlage B, et al.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. <span><span class="ref-journal"><em>Nature</em>. </span>2004;<span class="ref-vol">432</span>(7014):173\xe2\x80\x93178.</span> [<a href="/pubmed/15538359" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Therapeutic+silencing+of+an+endogenous+gene+by+systemic+administration+of+modified+siRNAs&amp;author=J+Soutschek&amp;author=A+Akinc&amp;author=B+Bramlage&amp;volume=432&amp;issue=7014&amp;publication_year=2004&amp;pages=173-178&amp;pmid=15538359&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="citation">Judge AD, Bola G, Lee ACH, MacLachlan I. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. <span><span class="ref-journal"><em>Molecular Therapy</em>. </span>2006;<span class="ref-vol">13</span>(3):494\xe2\x80\x93505.</span> [<a href="/pubmed/16343994" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+Therapy&amp;title=Design+of+noninflammatory+synthetic+siRNA+mediating+potent+gene+silencing+in+vivo&amp;author=AD+Judge&amp;author=G+Bola&amp;author=ACH+Lee&amp;author=I+MacLachlan&amp;volume=13&amp;issue=3&amp;publication_year=2006&amp;pages=494-505&amp;pmid=16343994&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="citation">Carstea ED, Hough S, Wiederholt K, Welch PJ. State-of-the-art modified RNAi compounds for therapeutics. <span><span class="ref-journal"><em>IDrugs</em>. </span>2005;<span class="ref-vol">8</span>(8):642\xe2\x80\x93647.</span> [<a href="/pubmed/16044372" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=IDrugs&amp;title=State-of-the-art+modified+RNAi+compounds+for+therapeutics&amp;author=ED+Carstea&amp;author=S+Hough&amp;author=K+Wiederholt&amp;author=PJ+Welch&amp;volume=8&amp;issue=8&amp;publication_year=2005&amp;pages=642-647&amp;pmid=16044372&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="citation">de Jonge J, Holtrop M, Wilschut J, Huckriede A. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs. <span><span class="ref-journal"><em>Gene Therapy</em>. </span>2006;<span class="ref-vol">13</span>(5):400\xe2\x80\x93411.</span> [<a href="/pubmed/16267567" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Therapy&amp;title=Reconstituted+influenza+virus+envelopes+as+an+efficient+carrier+system+for+cellular+delivery+of+small-interfering+RNAs&amp;author=J+de+Jonge&amp;author=M+Holtrop&amp;author=J+Wilschut&amp;author=A+Huckriede&amp;volume=13&amp;issue=5&amp;publication_year=2006&amp;pages=400-411&amp;pmid=16267567&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="citation">Kimchi-Sarfaty C, Brittain S, Garfield S, Caplen NJ, Tang Q, Gottesman MM. Efficient delivery of RNA interference effectors via in vitro-packaged SV40 pseudovirions. <span><span class="ref-journal"><em>Human Gene Therapy</em>. </span>2005;<span class="ref-vol">16</span>(9):1110\xe2\x80\x931115.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1618762/">PMC free article</a>]</span> [<a href="/pubmed/16149909" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+Gene+Therapy&amp;title=Efficient+delivery+of+RNA+interference+effectors+via+in+vitro-packaged+SV40+pseudovirions&amp;author=C+Kimchi-Sarfaty&amp;author=S+Brittain&amp;author=S+Garfield&amp;author=NJ+Caplen&amp;author=Q+Tang&amp;volume=16&amp;issue=9&amp;publication_year=2005&amp;pages=1110-1115&amp;pmid=16149909&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="citation">Uprichard SL, Boyd B, Althage A, Chisari FV. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. <span><span class="ref-journal"><em>Proceedings of the National Academy of Sciences of the United States of America</em>. </span>2005;<span class="ref-vol">102</span>(3):773\xe2\x80\x93778.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC545555/">PMC free article</a>]</span> [<a href="/pubmed/15640346" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;title=Clearance+of+hepatitis+B+virus+from+the+liver+of+transgenic+mice+by+short+hairpin+RNAs&amp;author=SL+Uprichard&amp;author=B+Boyd&amp;author=A+Althage&amp;author=FV+Chisari&amp;volume=102&amp;issue=3&amp;publication_year=2005&amp;pages=773-778&amp;pmid=15640346&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="citation">Dittgen T, Nimmerjahn A, Komai S, et al.  Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. <span><span class="ref-journal"><em>Proceedings of the National Academy of Sciences of the United States of America</em>. </span>2004;<span class="ref-vol">101</span>(52):18206\xe2\x80\x9318211.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC539748/">PMC free article</a>]</span> [<a href="/pubmed/15608064" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;title=Lentivirus-based+genetic+manipulations+of+cortical+neurons+and+their+optical+and+electrophysiological+monitoring+in+vivo&amp;author=T+Dittgen&amp;author=A+Nimmerjahn&amp;author=S+Komai&amp;volume=101&amp;issue=52&amp;publication_year=2004&amp;pages=18206-18211&amp;pmid=15608064&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47">47. <span class="citation">Godfrey A, Anderson J, Papanastasiou A, Takeuchi Y, Boshoff C. Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. <span><span class="ref-journal"><em>Blood</em>. </span>2005;<span class="ref-vol">105</span>(6):2510\xe2\x80\x932518.</span> [<a href="/pubmed/15572586" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Inhibiting+primary+effusion+lymphoma+by+lentiviral+vectors+encoding+short+hairpin+RNA&amp;author=A+Godfrey&amp;author=J+Anderson&amp;author=A+Papanastasiou&amp;author=Y+Takeuchi&amp;author=C+Boshoff&amp;volume=105&amp;issue=6&amp;publication_year=2005&amp;pages=2510-2518&amp;pmid=15572586&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48">48. <span class="citation">Ralph GS, Radcliffe PA, Day DM, et al.  Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. <span><span class="ref-journal"><em>Nature Medicine</em>. </span>2005;<span class="ref-vol">11</span>(4):429\xe2\x80\x93433.</span> [<a href="/pubmed/15768029" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Medicine&amp;title=Silencing+mutant+SOD1+using+RNAi+protects+against+neurodegeneration+and+extends+survival+in+an+ALS+model&amp;author=GS+Ralph&amp;author=PA+Radcliffe&amp;author=DM+Day&amp;volume=11&amp;issue=4&amp;publication_year=2005&amp;pages=429-433&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B49">49. <span class="citation">Raoul C, Abbas-Terki T, Bensadoun J-C, et al.  Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. <span><span class="ref-journal"><em>Nature Medicine</em>. </span>2005;<span class="ref-vol">11</span>(4):423\xe2\x80\x93428.</span> [<a href="/pubmed/15768028" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Medicine&amp;title=Lentiviral-mediated+silencing+of+SOD1+through+RNA+interference+retards+disease+onset+and+progression+in+a+mouse+model+of+ALS&amp;author=C+Raoul&amp;author=T+Abbas-Terki&amp;author=J-C+Bensadoun&amp;volume=11&amp;issue=4&amp;publication_year=2005&amp;pages=423-428&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B50">50. <span class="citation">Bot I, Guo J, Van Eck M, et al.  Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to persistent knockdown of CCR2 function in vivo. <span><span class="ref-journal"><em>Blood</em>. </span>2005;<span class="ref-vol">106</span>(4):1147\xe2\x80\x931153.</span> [<a href="/pubmed/15886324" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Lentiviral+shRNA+silencing+of+murine+bone+marrow+cell+CCR2+leads+to+persistent+knockdown+of+CCR2+function+in+vivo&amp;author=I+Bot&amp;author=J+Guo&amp;author=M+Van+Eck&amp;volume=106&amp;issue=4&amp;publication_year=2005&amp;pages=1147-1153&amp;pmid=15886324&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B51">51. <span class="citation">Yi Y, Hahm SH, Lee KH. Retroviral gene therapy: safety issues and possible solutions. <span><span class="ref-journal"><em>Current Gene Therapy</em>. </span>2005;<span class="ref-vol">5</span>(1):25\xe2\x80\x9335.</span> [<a href="/pubmed/15638709" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Current+Gene+Therapy&amp;title=Retroviral+gene+therapy:+safety+issues+and+possible+solutions&amp;author=Y+Yi&amp;author=SH+Hahm&amp;author=KH+Lee&amp;volume=5&amp;issue=1&amp;publication_year=2005&amp;pages=25-35&amp;pmid=15638709&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B52">52. <span class="citation">Palmer DJ, Ng P. Helper-dependent adenoviral vectors for gene therapy. <span><span class="ref-journal"><em>Human Gene Therapy</em>. </span>2005;<span class="ref-vol">16</span>(1):1\xe2\x80\x9316.</span> [<a href="/pubmed/15703484" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+Gene+Therapy&amp;title=Helper-dependent+adenoviral+vectors+for+gene+therapy&amp;author=DJ+Palmer&amp;author=P+Ng&amp;volume=16&amp;issue=1&amp;publication_year=2005&amp;pages=1-16&amp;pmid=15703484&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B53">53. <span class="citation">Wolkowicz R, Nolan GP. Gene therapy progress and prospects: novel gene therapy approaches for AIDS. <span><span class="ref-journal"><em>Gene Therapy</em>. </span>2005;<span class="ref-vol">12</span>(6):467\xe2\x80\x93476.</span> [<a href="/pubmed/15703764" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Therapy&amp;title=Gene+therapy+progress+and+prospects:+novel+gene+therapy+approaches+for+AIDS&amp;author=R+Wolkowicz&amp;author=GP+Nolan&amp;volume=12&amp;issue=6&amp;publication_year=2005&amp;pages=467-476&amp;pmid=15703764&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B54">54. <span class="citation">Jia W, Zhou Q. Viral vectors for cancer gene therapy: viral dissemination and tumor targeting. <span><span class="ref-journal"><em>Current Gene Therapy</em>. </span>2005;<span class="ref-vol">5</span>(1):133\xe2\x80\x93142.</span> [<a href="/pubmed/15638717" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Current+Gene+Therapy&amp;title=Viral+vectors+for+cancer+gene+therapy:+viral+dissemination+and+tumor+targeting&amp;author=W+Jia&amp;author=Q+Zhou&amp;volume=5&amp;issue=1&amp;publication_year=2005&amp;pages=133-142&amp;pmid=15638717&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B55">55. <span class="citation">Wurdinger T, Verheije MH, Broen K, et al.  Soluble receptor-mediated targeting of mouse hepatitis coronavirus to the human epidermal growth factor receptor. <span><span class="ref-journal"><em>Journal of Virology</em>. </span>2005;<span class="ref-vol">79</span>(24):15314\xe2\x80\x9315322.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1316040/">PMC free article</a>]</span> [<a href="/pubmed/16306602" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Virology&amp;title=Soluble+receptor-mediated+targeting+of+mouse+hepatitis+coronavirus+to+the+human+epidermal+growth+factor+receptor&amp;author=T+Wurdinger&amp;author=MH+Verheije&amp;author=K+Broen&amp;volume=79&amp;issue=24&amp;publication_year=2005&amp;pages=15314-15322&amp;pmid=16306602&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B56">56. <span class="citation">Xiong Z, Cheng Z, Zhang X, et al.  Imaging chemically modified adenovirus for targeting tumors expressing integrin {alpha}v{beta}3 in living mice with mutant herpes simplex virus type 1 thymidine Kinase PET reporter gene. <span><span class="ref-journal"><em>Journal of Nuclear Medicine</em>. </span>2006;<span class="ref-vol">47</span>(1):130\xe2\x80\x93139.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4154793/">PMC free article</a>]</span> [<a href="/pubmed/16391197" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Nuclear+Medicine&amp;title=Imaging+chemically+modified+adenovirus+for+targeting+tumors+expressing+integrin+{alpha}v{beta}3+in+living+mice+with+mutant+herpes+simplex+virus+type+1+thymidine+Kinase+PET+reporter+gene&amp;author=Z+Xiong&amp;author=Z+Cheng&amp;author=X+Zhang&amp;volume=47&amp;issue=1&amp;publication_year=2006&amp;pages=130-139&amp;pmid=16391197&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B57">57. <span class="citation">Monahan PE, Jooss K, Sands MS. Safety of adeno-associated virus gene therapy vectors: a current evaluation. <span><span class="ref-journal"><em>Expert Opinion on Drug Safety</em>. </span>2002;<span class="ref-vol">1</span>(1):79\xe2\x80\x9391.</span> [<a href="/pubmed/12904163" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opinion+on+Drug+Safety&amp;title=Safety+of+adeno-associated+virus+gene+therapy+vectors:+a+current+evaluation&amp;author=PE+Monahan&amp;author=K+Jooss&amp;author=MS+Sands&amp;volume=1&amp;issue=1&amp;publication_year=2002&amp;pages=79-91&amp;pmid=12904163&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B58">58. <span class="citation">Kappes JC, Wu X. Safety considerations in vector development. <span><span class="ref-journal"><em>Somatic Cell and Molecular Genetics</em>. </span>2001;<span class="ref-vol">26</span>(1&#x02013;6):147\xe2\x80\x93158.</span> [<a href="/pubmed/12465466" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Somatic+Cell+and+Molecular+Genetics&amp;title=Safety+considerations+in+vector+development&amp;author=JC+Kappes&amp;author=X+Wu&amp;volume=26&amp;issue=1&#x02013;6&amp;publication_year=2001&amp;pages=147-158&amp;pmid=12465466&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B59">59. <span class="citation">Guo S, Tschammer N, Mohammed S, Guo P. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA. <span><span class="ref-journal"><em>Human Gene Therapy</em>. </span>2005;<span class="ref-vol">16</span>(9):1097\xe2\x80\x931109.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2837361/">PMC free article</a>]</span> [<a href="/pubmed/16149908" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+Gene+Therapy&amp;title=Specific+delivery+of+therapeutic+RNAs+to+cancer+cells+via+the+dimerization+mechanism+of+phi29+motor+pRNA&amp;author=S+Guo&amp;author=N+Tschammer&amp;author=S+Mohammed&amp;author=P+Guo&amp;volume=16&amp;issue=9&amp;publication_year=2005&amp;pages=1097-1109&amp;pmid=16149908&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B60">60. <span class="citation">S&#x000f8;rensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. <span><span class="ref-journal"><em>Journal of Molecular Biology</em>. </span>2003;<span class="ref-vol">327</span>(4):761\xe2\x80\x93766.</span> [<a href="/pubmed/12654261" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+Molecular+Biology&amp;title=Gene+silencing+by+systemic+delivery+of+synthetic+siRNAs+in+adult+mice&amp;author=DR+S&#x000f8;rensen&amp;author=M+Leirdal&amp;author=M+Sioud&amp;volume=327&amp;issue=4&amp;publication_year=2003&amp;pages=761-766&amp;pmid=12654261&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B61">61. <span class="citation">Luo MC, Zhang DQ, Ma SW, et al.  An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons. <span><span class="ref-journal"><em>Molecular Pain</em>. </span>2005;<span class="ref-vol">1</span>:29.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1253531/">PMC free article</a>]</span> [<a href="/pubmed/16191203" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Molecular+Pain&amp;title=An+efficient+intrathecal+delivery+of+small+interfering+RNA+to+the+spinal+cord+and+peripheral+neurons&amp;author=MC+Luo&amp;author=DQ+Zhang&amp;author=SW+Ma&amp;volume=1&amp;publication_year=2005&amp;pages=29&amp;pmid=16191203&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B62">62. <span class="citation">Pal A, Ahmad A, Khan S, et al.  Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer. <span><span class="ref-journal"><em>International Journal of Oncology</em>. </span>2005;<span class="ref-vol">26</span>(4):1087\xe2\x80\x931091.</span> [<a href="/pubmed/15754006" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=International+Journal+of+Oncology&amp;title=Systemic+delivery+of+RafsiRNA+using+cationic+cardiolipin+liposomes+silences+Raf-1+expression+and+inhibits+tumor+growth+in+xenograft+model+of+human+prostate+cancer&amp;author=A+Pal&amp;author=A+Ahmad&amp;author=S+Khan&amp;volume=26&amp;issue=4&amp;publication_year=2005&amp;pages=1087-1091&amp;pmid=15754006&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B63">63. <span class="citation">Omidi Y, Barar J, Akhtar S. Toxicogenomics of cationic lipid-based vectors for gene therapy: impact of microarray technology. <span><span class="ref-journal"><em>Current Drug Delivery</em>. </span>2005;<span class="ref-vol">2</span>(4):429\xe2\x80\x93441.</span> [<a href="/pubmed/16305446" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Current+Drug+Delivery&amp;title=Toxicogenomics+of+cationic+lipid-based+vectors+for+gene+therapy:+impact+of+microarray+technology&amp;author=Y+Omidi&amp;author=J+Barar&amp;author=S+Akhtar&amp;volume=2&amp;issue=4&amp;publication_year=2005&amp;pages=429-441&amp;pmid=16305446&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B64">64. <span class="citation">Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. <span><span class="ref-journal"><em>Gene Therapy</em>. </span>2005;<span class="ref-vol">12</span>(5):461\xe2\x80\x93466.</span> [<a href="/pubmed/15616603" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Therapy&amp;title=RNAi-mediated+gene-targeting+through+systemic+application+of+polyethylenimine+(PEI)-complexed+siRNA+in+vivo&amp;author=B+Urban-Klein&amp;author=S+Werth&amp;author=S+Abuharbeid&amp;author=F+Czubayko&amp;author=A+Aigner&amp;volume=12&amp;issue=5&amp;publication_year=2005&amp;pages=461-466&amp;pmid=15616603&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B65">65. <span class="citation">Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. <span><span class="ref-journal"><em>Cancer Research</em>. </span>2004;<span class="ref-vol">64</span>(10):3365\xe2\x80\x933370.</span> [<a href="/pubmed/15150085" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Research&amp;title=A+small+interfering+RNA+targeting+vascular+endothelial+growth+factor+as+cancer+therapeutics&amp;author=Y+Takei&amp;author=K+Kadomatsu&amp;author=Y+Yuzawa&amp;author=S+Matsuo&amp;author=T+Muramatsu&amp;volume=64&amp;issue=10&amp;publication_year=2004&amp;pages=3365-3370&amp;pmid=15150085&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B66">66. <span class="citation">Takeshita F, Minakuchi Y, Nagahara S, et al.  Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. <span><span class="ref-journal"><em>Proceedings of the National Academy of Sciences of the United States of America</em>. </span>2005;<span class="ref-vol">102</span>(34):12177\xe2\x80\x9312182.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1183487/">PMC free article</a>]</span> [<a href="/pubmed/16091473" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;title=Efficient+delivery+of+small+interfering+RNA+to+bone-metastatic+tumors+by+using+atelocollagen+in+vivo&amp;author=F+Takeshita&amp;author=Y+Minakuchi&amp;author=S+Nagahara&amp;volume=102&amp;issue=34&amp;publication_year=2005&amp;pages=12177-12182&amp;pmid=16091473&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B67">67. <span class="citation">Song E, Zhu P, Lee S-K, et al.  Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. <span><span class="ref-journal"><em>Nature Biotechnology</em>. </span>2005;<span class="ref-vol">23</span>(6):709\xe2\x80\x93717.</span> [<a href="/pubmed/15908939" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Biotechnology&amp;title=Antibody+mediated+in+vivo+delivery+of+small+interfering+RNAs+via+cell-surface+receptors&amp;author=E+Song&amp;author=P+Zhu&amp;author=S-K+Lee&amp;volume=23&amp;issue=6&amp;publication_year=2005&amp;pages=709-717&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B68">68. <span class="citation">Pirollo KF, Zon G, Rait A, et al.  Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery. <span><span class="ref-journal"><em>Human Gene Therapy</em>. </span>2006;<span class="ref-vol">17</span>(1):117\xe2\x80\x93124.</span> [<a href="/pubmed/16409130" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+Gene+Therapy&amp;title=Tumor-targeting+nanoimmunoliposome+complex+for+short+interfering+RNA+delivery&amp;author=KF+Pirollo&amp;author=G+Zon&amp;author=A+Rait&amp;volume=17&amp;issue=1&amp;publication_year=2006&amp;pages=117-124&amp;pmid=16409130&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B69">69. <span class="citation">Schiffelers RM, Ansari A, Xu J, et al.  Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. <span><span class="ref-journal"><em>Nucleic Acids Research</em>. </span>2004;<span class="ref-vol">32</span>(19):e149.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC528817/">PMC free article</a>]</span> [<a href="/pubmed/15520458" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Research&amp;title=Cancer+siRNA+therapy+by+tumor+selective+delivery+with+ligand-targeted+sterically+stabilized+nanoparticle&amp;author=RM+Schiffelers&amp;author=A+Ansari&amp;author=J+Xu&amp;volume=32&amp;issue=19&amp;publication_year=2004&amp;pages=e149&amp;pmid=15520458&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B70">70. <span class="citation">Kim B, Tang Q, Biswas PS, et al.  Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. <span><span class="ref-journal"><em>American Journal of Pathology</em>. </span>2004;<span class="ref-vol">165</span>(6):2177\xe2\x80\x932185.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1618707/">PMC free article</a>]</span> [<a href="/pubmed/15579459" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=American+Journal+of+Pathology&amp;title=Inhibition+of+ocular+angiogenesis+by+siRNA+targeting+vascular+endothelial+growth+factor+pathway+genes:+therapeutic+strategy+for+herpetic+stromal+keratitis&amp;author=B+Kim&amp;author=Q+Tang&amp;author=PS+Biswas&amp;volume=165&amp;issue=6&amp;publication_year=2004&amp;pages=2177-2185&amp;pmid=15579459&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B71">71. <span class="citation">Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. <span><span class="ref-journal"><em>Nature</em>. </span>2001;<span class="ref-vol">411</span>(6836):494\xe2\x80\x93498.</span> [<a href="/pubmed/11373684" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Duplexes+of+21-nucleotide+RNAs+mediate+RNA+interference+in+cultured+mammalian+cells&amp;author=SM+Elbashir&amp;author=J+Harborth&amp;author=W+Lendeckel&amp;author=A+Yalcin&amp;author=K+Weber&amp;volume=411&amp;issue=6836&amp;publication_year=2001&amp;pages=494-498&amp;pmid=11373684&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1559924&amp;issue-id=131010&amp;journal-id=94&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Journal of Biomedicine and Biotechnology</span> are provided here courtesy of <strong>Hindawi Limited</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1559924/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1559924/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1559924/pdf/JBB2006-63675.pdf">PDF (8.3M)</a></li> | <li><a href="#" data-citationid="PMC1559924" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1559924%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1559924%2F&amp;text=Targeted%20Delivery%20of%20siRNA"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1559924%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="17057365" data-aiid="1559924" data-aid="1559924" data-iid="131010" data-domainid="94" data-domain="jbb" data-accid="PMC1559924" data-md5="ce3fd4958d1ee455b52f17a3f34ebb8a"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:19:15-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1AA2A3E99A02E10000000007120711&amp;ncbi_session=8A1AA2A3E99ACD21_1810SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1559924%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=jbb&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1559924/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1AA2A3E99ACD21_1810SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'